Journey Medical Corp Proceeds from Issuance of Redeemable Convertible Preferred Stock
Journey Medical Corp (DERM) reported Proceeds from Issuance of Redeemable Convertible Preferred Stock of $18.97 million for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-31.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock · last filed 2023-03-31
- Journey Medical Corp proceeds from issuance of redeemable convertible preferred stock for the quarter ending 2021-12-31 was $0.00.
- Journey Medical Corp proceeds from issuance of redeemable convertible preferred stock for the quarter ending 2021-09-30 was $4.63M.
- Journey Medical Corp proceeds from issuance of redeemable convertible preferred stock for the quarter ending 2021-06-30 was $1.79M.
- Journey Medical Corp proceeds from issuance of redeemable convertible preferred stock for the quarter ending 2021-03-31 was $12.54M.
- Journey Medical Corp proceeds from issuance of redeemable convertible preferred stock for fiscal 2021 was $18.97M.
- Journey Medical Corp proceeds from issuance of redeemable convertible preferred stock for fiscal 2020 was $0.00.
| Period end | Proceeds from Issuance of Redeemable Convertible Preferred Stock 3 month | Proceeds from Issuance of Redeemable Convertible Preferred Stock 6 month | Proceeds from Issuance of Redeemable Convertible Preferred Stock 9 month | Proceeds from Issuance of Redeemable Convertible Preferred Stock 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $4.63M derived: sum of 2 quarters · filed 2023-03-31 | $6.43M derived: sum of 3 quarters · filed 2023-03-31 | $18.97M 10-K · filed 2023-03-31 |
| 2021-09-30 | $4.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $6.43M derived: sum of 2 quarters · filed 2022-11-10 | $18.97M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $1.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $14.33M 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | $12.54M 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | $0.00 10-K · filed 2022-03-28 |